• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 20 SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 20 SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Catalog Number 20-260
Medical Device Problem Codes Device Appears to Trigger Rejection (1524); Material Rupture (1546)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 11/06/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Healthcare professional reported "capsular contracture baker grade iv and intracapsular leak" confirmed by mammogram and ultrasound.This record is for the left side.Device remains implanted and it is unknown if the device will be returned.
 
Additional Manufacturer Narrative
The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture baker grade iv, rupture a review of the device history record has been completed.No deviations or non-conformances noted.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: b.5, d.6b, h.6.
 
Event or Problem Description
Device was explanted and replaced.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: d1, d2, d4, d9, h3, h4, h6 device evaluation: per the analysis performed, the assessments of the complaints and any potential manufacturing issue are displayed along with any further actions required: ¿ rupture: not observed through visual inspection.¿ capsular contracture: unable to observe through visual inspection as it is a physiological phenomenon.None of the other observations performed during the device analysis (deformation, crease and wear abrasion) are found to be potentially related to the manufacturing process, and, therefore, no further actions are required for these observations.
 
Event or Problem Description
Healthcare professional reported "capsular contracture baker grade iv and intracapsular leak" confirmed by mammogram and ultrasound.This record is for the left side.Device remains implanted and it is unknown if the device will be returned.
 
Additional Manufacturer Narrative
Correction to g.3.Aware date of supplemental medwatch #2.Aware date should have been listed as 3-feb-2026.Clarification to h6 adverse event problem: un-reporting a0412 material rupture as the device was found intact during explant surgery.A review of the device history record has been completed.No deviations or non-conformances noted.
 
Event or Problem Description
Healthcare professional reported "capsular contracture baker grade iv and intracapsular leak" confirmed by mammogram and ultrasound.Later healthcare professional reported "no leak in implant" and "intact".This record is for the left side.Device was explanted.Capsulectomy was performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 20 SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
la aurora de heredia
CS 
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
la aurora de heredia
CS  
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
8479366324
MDR Report Key23769645
Report Number9617229-2025-21510
Device Sequence Number13183503
Product Code FTR
UDI-Device Identifier10888628001640
UDI-Public(01)10888628001640(10)2715857(11)150313(17)200213
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 04/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/13/2020
Device Catalogue Number20-260
Device Lot Number2715857
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 11/20/2025
Supplement Date Received by Manufacturer01/12/2026
04/06/2026
04/22/2026
Initial Report FDA Received Date12/10/2025
Supplement Report FDA Received Date01/23/2026
04/17/2026
04/24/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/13/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient SexFemale
Patient Weight50 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-